Show simple item record

AuthorBhat, Ajaz A.
AuthorNisar, Sabah
AuthorSingh, Mayank
AuthorAshraf, Bazella
AuthorMasoodi, Tariq
AuthorPrasad, Chandra P.
AuthorSharma, Atul
AuthorMaacha, Selma
AuthorKaredath, Thasni
AuthorHashem, Sheema
AuthorYasin, Syed Besina
AuthorBagga, Puneet
AuthorReddy, Ravinder
AuthorFrennaux, Michael P.
AuthorUddin, Shahab
AuthorDhawan, Punita
AuthorHaris, Mohammad
AuthorMacha, Muzafar A.
Available date2023-12-13T10:58:01Z
Publication Date2022-08-01
Publication NameCancer Communications
Identifierhttp://dx.doi.org/10.1002/cac2.12295
CitationBhat, AA, Nisar, S, Singh, M, Ashraf, B, Masoodi, T, Prasad, CP, et al. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. Cancer Commun. 2022; 42: 689–715. https://doi.org/10.1002/cac2.12295
ISSN2523-3548
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133455385&origin=inward
URIhttp://hdl.handle.net/10576/50384
AbstractColorectal cancer (CRC) is a predominant life-threatening cancer, with liver and peritoneal metastases as the primary causes of death. Intestinal inflammation, a known CRC risk factor, nurtures a local inflammatory environment enriched with tumor cells, endothelial cells, immune cells, cancer-associated fibroblasts, immunosuppressive cells, and secretory growth factors. The complex interactions of aberrantly expressed cytokines, chemokines, growth factors, and matrix-remodeling enzymes promote CRC pathogenesis and evoke systemic responses that affect disease outcomes. Mounting evidence suggests that these cytokines and chemokines play a role in the progression of CRC through immunosuppression and modulation of the tumor microenvironment, which is partly achieved by the recruitment of immunosuppressive cells. These cells impart features such as cancer stem cell-like properties, drug resistance, invasion, and formation of the premetastatic niche in distant organs, promoting metastasis and aggressive CRC growth. A deeper understanding of the cytokine- and chemokine-mediated signaling networks that link tumor progression and metastasis will provide insights into the mechanistic details of disease aggressiveness and facilitate the development of novel therapeutics for CRC. Here, we summarized the current knowledge of cytokine- and chemokine-mediated crosstalk in the inflammatory tumor microenvironment, which drives immunosuppression, resistance to therapeutics, and metastasis during CRC progression. We also outlined the potential of this crosstalk as a novel therapeutic target for CRC. The major cytokine/chemokine pathways involved in cancer immunotherapy are also discussed in this review.
SponsorOpen access publication is supported by Qatar National Library.
Languageen
PublisherWiley
Subjectchemokine
colorectal cancer
cytokine
drug resistance
epithelial-mesenchymal transition
immunosuppression
immunotherapy
inflammation
metastasis
tumor microenvironment
TitleCytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
TypeArticle Review
Pagination689-715
Issue Number8
Volume Number42
ESSN2523-3548
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record